Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP

被引:102
作者
Young, Mark T. [1 ]
Pelegrin, Pablo [1 ]
Surprenant, Annmarie [1 ]
机构
[1] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
基金
英国惠康基金;
关键词
D O I
10.1124/mol.106.030163
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonist properties of the P2X(7) receptor (P2X(7)R) differ strikingly from other P2X receptors in two main ways: high concentrations of ATP (> 100 mu M) are required to activate the receptor, and the ATP analog 2', 3'-O-(4-benzoyl-benzoyl) ATP (BzATP) is both more potent than ATP and evokes a higher maximum current. However, there are striking species differences in these properties. We sought to exploit the large differences in ATP and BzATP responses between rat and mouse P2X(7)R to delineate regions or specific residues that may be responsible for the unique actions of these agonists at the P2X(7)R. We measured membrane currents in response to ATP and BzATP at wild-type rat and mouse P2X(7)R, at chimeric P2X(7)Rs, and at mouse P2X(7)Rs bearing point mutations. Wild-type rat P2X(7)R was 10 times more sensitive to ATP and 100 times more sensitive to BzATP than wild-type mouse P2X(7)R. We found that agonist EC50 values were determined solely by the ectodomain of the P2X(7)R. Two segments (residues 115-136 and 282-288), when transposed together, converted mouse sensitivities to those of rat. Point mutations through these regions revealed a single residue, asparagine(284), in the rat P2X(7)R that fully accounted for the 10-fold difference in ATP sensitivity, whereas the 100-fold difference in BzATP sensitivity required the transfer of both Lys(127) and Asn(284) from rat to mouse. Thus, single amino acid differences between species can account for large changes in agonist effectiveness and differentiate between the two widely used agonists at P2X(7) receptors.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 40 条
  • [31] Altered cytokine production in mice lacking P2X7 receptors
    Solle, M
    Labasi, J
    Perregaux, DG
    Stam, E
    Petrushova, N
    Koller, BH
    Griffiths, RJ
    Gabel, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) : 125 - 132
  • [32] Cloning, tissue distribution and functional characterization of the chicken P2X1 receptor
    Soto, F
    Krause, U
    Borchardt, K
    Ruppelt, A
    [J]. FEBS LETTERS, 2003, 533 (1-3) : 54 - 58
  • [33] P2X(4): An ATP-activated ionotropic receptor cloned from rat brain
    Soto, F
    GarciaGuzman, M
    GomezHernandez, JM
    Hollmann, M
    Karschin, C
    Stuhmer, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) : 3684 - 3688
  • [34] The cytolytic P-2Z receptor for extracellular ATP identified as a P-2X receptor (P2X(7))
    Surprenant, A
    Rassendren, F
    Kawashima, E
    North, RA
    Buell, G
    [J]. SCIENCE, 1996, 272 (5262) : 735 - 738
  • [35] N-linked glycosylation is essential for the functional expression of the recombinant P2X2 receptor
    Torres, GE
    Egan, TM
    Voigt, MM
    [J]. BIOCHEMISTRY, 1998, 37 (42) : 14845 - 14851
  • [36] P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1β release
    Verhoef, PA
    Estacion, M
    Schilling, W
    Dubyak, GR
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (11) : 5728 - 5738
  • [37] Molecular properties of ATP-gated P2X receptor ion channels
    Vial, C
    Roberts, JA
    Evans, RJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (09) : 487 - 493
  • [38] Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel
    Wiley, JS
    Gargett, CE
    Zhang, W
    Snook, MB
    Jamieson, GA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (05): : C1224 - C1231
  • [39] Identification of Thr283 as a key determinant of P2X7 receptor function
    Young, M. T.
    Pelegrin, P.
    Surprenant, A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (03) : 261 - 268
  • [40] Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors
    Zemkova, H
    He, ML
    Koshimizu, T
    Stojilkovic, SS
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (31) : 6968 - 6978